Volume 25, Issue 3 pp. 458-465
Original Article

Maintaining professional activity during breast cancer treatment

G. Ganem DR, MD

Corresponding Author

G. Ganem DR, MD

Clinique Victor Hugo, Le Mans, France

Correspondence address: Gérard Ganem, Clinique Victor Hugo, 18 rue Victor Hugo, 72000 Le Mans, France (e-mail: [email protected]).Search for more papers by this author
E.-C. Antoine DR, MD

E.-C. Antoine DR, MD

Clinique Hartmann, Neuilly sur Seine, France

Search for more papers by this author
C. Touboul BSc

C. Touboul BSc

Statistician

Kantar Health, Montrouge, France

Search for more papers by this author
H. Naman DR, MD

H. Naman DR, MD

Centre Azuréen de Cancérologie, Mougins, France

Search for more papers by this author
N. Dohollou DR, MD

N. Dohollou DR, MD

Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France

Search for more papers by this author
T. Facchini DR, MD

T. Facchini DR, MD

Polyclinique de Courlancy, Reims, France

Search for more papers by this author
Y. Coscas DR, MD

Y. Coscas DR, MD

Clinique de la Porte de Saint Cloud, Boulogne-Billancourt, France

Search for more papers by this author
A. Lortholary DR, MD

A. Lortholary DR, MD

Centre Catherine de Sienne, Nantes, France

Search for more papers by this author
S. Catala DR, MD

S. Catala DR, MD

Clinique Saint Pierre, Perpignan, France

Search for more papers by this author
S. Jacquot DR, MD

S. Jacquot DR, MD

Clinique Clémentville, Montpellier, France

Search for more papers by this author
C. Lhomel MSc

C. Lhomel MSc

Institutional Department, Roche, Boulogne-Billancourt, France

Search for more papers by this author
F. Eisinger PR, MD, PhD

F. Eisinger PR, MD, PhD

Institut Paoli-Calmettes, Marseille, France

Search for more papers by this author
First published: 18 February 2016
Citations: 7

Abstract

The question of returning to work and pursuing professional activity during cancer treatment is an increasingly important consideration. The present work focuses on factors affecting the feasibility of maintaining professional activity during treatment for breast cancer, for women who wished to do so. Written questionnaires were collected from 216 patients between March and November 2012. Since the onset of their treatment, 31.4% of the women (68/216) had not been on sick-leave. The main factors associated with the pursuit of professional activity were: considering the availability of their physician to answer questions as unimportant [OR = 18.83 (3.60–98.53); P ≤ 0.05]; considering the diagnosis of cancer as likely to have a weak impact on career perspectives [OR = 4.07 (2.49–6.64); P ≤ 0.05]; not having any children in the household [OR = 3.87 (2.38–6.28); P ≤ 0.05]; being in a managerial position [OR = 3.13 (1.88–5.21); P ≤ 0.05]. Negative predictive factors were: physician mentioning adverse effects of the treatment [OR = 0.31 (0.16–0.58); P ≤ 0.05], and patient rating workload as high [OR = 0.26 (0.15–0.46); P ≤ 0.05]. As a result of advances in therapeutic strategies, more patients will expect healthcare professionals, as well as employers and occupational health societies, to prioritise issues pertaining to the maintenance of professional activities during cancer treatment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.